Author:
Rao Shilpa,Goyal Aditi,Johnson Allen,Sadashiva Nishanth,Kulanthaivelu Karthik,Vazhayil Vikas,Santosh Vani
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Rosenblum MK, Ellison DW, Huse JT. Polymorphous low-grade neuroepithelial tumor of the young. In Reifenberger G (ed) WHO classification of tumours editorial board. central nervous system tumours. 5th edn. international agency for research on cancer, Lyon(France)
2. Huse JT, Snuderl M, Jones DTW et al (2017) Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway. Acta Neuropathol 133:417–249
3. Zhu Z, Dong H, Wu J et al (2021) Targeted genomic profiling revealed a unique clinical phenotype in intrahepatic cholangiocarcinoma with fibroblast growth factor receptor rearrangement. Transl Oncol 14:101168
4. Baldia PH, Maurer A, Heide T et al (2016) Fibroblast growth factor receptor (FGFR) alterations in squamous differentiated bladder cancer: a putative therapeutic target for a small subgroup. Oncotarget 7:71429–71439
5. Broggi G, Certo F, Altieri R et al (2021). A “polymorphous low-grade neuroepithelial tumor of the young (PLNTY)” diagnosed in an adult. Report of a case and review of the literature. Surgical Neurology International 12:470.